Fem-Pop Stenting - Is Zilver PTX DES the ‘DeFacto” Stent to Deploy? - Krishna Rocha-Singh, MD, FSCAI

↳ This is a section part of Moment: CRT 2016 Endovascular - SFA Stenting

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Fem-Pop Stenting - Is Zilver PTX DES the ‘DeFacto” Stent to Deploy? presented by Krishna Rocha-Singh, MD, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Radiologists
  • Vascular Surgeons
  • Interventional Fellows

Session Name: SFA Stenting

Track: CRT 2016 Endovascular

Learning Objectives

Update in advances in endovascular procedures

Other Components in this Moment

Overview
SFA Intervention - Stenting as Definitive Therapy with New Stent Designs - D. Christopher Metzger, MD, FSCAI
Insights from the IMPERIAL and MAJESTIC SFA Studies - William Gray, MD, FSCAI
Fem-Pop Stenting - Is Zilver PTX DES the ‘DeFacto” Stent to Deploy? - Krishna Rocha-Singh, MD, FSCAI
Live Case #1 from Ochsner Heart and Vascular Institute - New Orleans, LA
Loading Simple Education